| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-11 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-11 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-10 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-10 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-09 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-09 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-08 |